Does MOLNUPIRAVIR Cause Product dose omission issue? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Product dose omission issue have been filed in association with MOLNUPIRAVIR (LAGEVRIO). This represents 1.6% of all adverse event reports for MOLNUPIRAVIR.
75
Reports of Product dose omission issue with MOLNUPIRAVIR
1.6%
of all MOLNUPIRAVIR reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product dose omission issue From MOLNUPIRAVIR?
Of the 75 reports, 1 (1.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLNUPIRAVIR. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does MOLNUPIRAVIR Cause?
Product use issue (706)
No adverse event (614)
Covid-19 (396)
Wrong technique in product usage process (380)
Product use in unapproved indication (296)
Diarrhoea (259)
Accidental underdose (207)
Product use complaint (206)
Rash (200)
Underdose (183)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which MOLNUPIRAVIR Alternatives Have Lower Product dose omission issue Risk?
MOLNUPIRAVIR vs MOLSIDOMINE
MOLNUPIRAVIR vs MOMELOTINIB
MOLNUPIRAVIR vs MOMETASONE
MOLNUPIRAVIR vs MOMETASONE FUROATE
MOLNUPIRAVIR vs MOMETASONE FUROATE\OLOPATADINE